4
Changes in Ownership
Atrium Therapeutics, Inc. Filed Acc 0001193125-26-170914
See Remarks acquired 102,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Kathleen P. See Remarks | 2026-04-20 | Grant or award | +102,500 | 131,361 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Kathleen P. See Remarks | 2026-04-20 | Grant or award · Stock Option (Right to Buy) | +205,000 | 205,000 | D: show line 2 in the form |
Loading xslF345X06/ownership.xml…